CD33 and systemic lupus erythematosus: Based on the assumption that accelerated activation and differentiation of SLE monocytes28–30 might be associated with flawed LAIR-1 and/or CD33 activity, we investigated patterns of LAIR-1 and CD33 expression on SLE monocytes.